Press "Enter" to skip to content

U.S. FDA approves Tandem’s predictive insulin pump software

The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care’s software program that uses readings from a continuous glucose monitor to predict and deliver corrective doses of insulin to patients using the company’s t:slim X2 insulin pump.

Original source: